Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2012; 18(12): 1404-1409
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1404
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1404
Table 5 Toxicity and complications in patients after 4-wk 3-dimensional conformal and control group after treatment n (%)
| 3D-CRT (n =67) | Control (n = 32) | P value | |
| Hematologic | |||
| Anemia | 33 (49.3) | 11 (34.4) | 0.198 |
| Thrombocytopenia | 21 (31.3) | 7 (21.9) | 0.475 |
| Leukocytopenia | 31 (46.7) | 6 (18.8) | 0.008 |
| Non-hemotologic | |||
| Reflux esophagitis | 28 (41.8) | 15 (46.9) | 0.669 |
| Pectoralgia | 29 (43.3) | 14 (43.8) | 1.000 |
| Perforation | 16 (23.9) | 12 (37.5) | 0.232 |
| Restenosis | 6 (9.0) | 26 (81.3) | < 0.05 |
| Nephrotoxicity | 21 (31.3) | 5 (15.6) | < 0.05 |
| Shift and brush off of stent | 8 (11.9) | 5 (15.6) | 0.751 |
- Citation: Jiang XJ, Song MQ, Xin YN, Gao YQ, Niu ZY, Tian ZB. Endoscopic stenting and concurrent chemoradiotherapy for advanced esophageal cancer: A case-control study. World J Gastroenterol 2012; 18(12): 1404-1409
- URL: https://www.wjgnet.com/1007-9327/full/v18/i12/1404.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i12.1404